AAAAAA

   
Results: 1-19 |
Results: 19
ANDREGG,CHARLES - COMMENTS FROM FRIENDS AND COLLEAGUES
Authors: QUINN AO FENNELLPUMPELLY H THOMPSON MM RALL LL BEASLEY H DAMERON LY FINNIE TC AYERS LF PENNEY HW HERNDON R KELSEY J
Citation: Ao. Quinn et al., ANDREGG,CHARLES - COMMENTS FROM FRIENDS AND COLLEAGUES, Photogrammetric engineering and remote sensing, 64(7), 1998, pp. 689
NEUROPSYCHOLOGICAL EFFECTS OF AVONEX(R) (INTERFERON-BETA-1A) IN RELAPSING MULTIPLE-SCLEROSIS (MS)
Authors: FISCHER JS PRIORE R JACOBS L COOKFAIR D RUDICK R HERNDON R RICHERT J SALAZAR A GOODKIN D GRANGER C SIMON J GRAFMAN J LEZAK M OREILLY K SCHACTER M SHUCARD D DAVIDSON A WENDE K
Citation: Js. Fischer et al., NEUROPSYCHOLOGICAL EFFECTS OF AVONEX(R) (INTERFERON-BETA-1A) IN RELAPSING MULTIPLE-SCLEROSIS (MS), Neurology, 50(4), 1998, pp. 1070-1070
CSF KAPPA-LIGHT-CHAINS AND GADOLINIUM-ENHANCING BRAIN-LESIONS AS PREDICTORS OF RESPONSE TO THERAPY WITH INTERFERON-BETA 1A (AVONEX(R)) IN PATIENTS WITH RELAPSING MULTIPLE-SCLEROSIS
Authors: RUDICK R COOKFAIR D SIMON J SIMONIAN N JACOBS L HERNDON R RICHERT J SALAZAR A FISCHER J GRANGER C GOODKIN D OREILLY K BOYLE S
Citation: R. Rudick et al., CSF KAPPA-LIGHT-CHAINS AND GADOLINIUM-ENHANCING BRAIN-LESIONS AS PREDICTORS OF RESPONSE TO THERAPY WITH INTERFERON-BETA 1A (AVONEX(R)) IN PATIENTS WITH RELAPSING MULTIPLE-SCLEROSIS, Neurology, 50(4), 1998, pp. 47001-47001
ENTACAPONE IMPROVES MOTOR FLUCTUATIONS IN LEVODOPA-TREATED PARKINSONS-DISEASE PATIENTS
Authors: KIEBURTZ K SHOULSON I FAHN S MCDERMOTT M KOLLER W LEWITT P NUTT J KURTH M BREWER M LEW M WELSH M WATERS C BENNETT J ROSTRUFFNER E FEIGIN A GARDINER I KURLAN R HAMMERSTAD J STONE C JANKOVIC J BEACH J TETRUD J KELKER K STANDAERT DG GROWDON JH TENNIS M GRAEFE K MARK MH KELLY SJ PAHWA R MCGUIRE D HUBBLE J FACTOR SA BROWN DL TUITE P SIME E LANG DL GREENE P WINFIELD H PAULSON G ZOOG K WEEKS C SHULTS C FONTAINE D JUNCOS JL WOOD C SHANNON K JAGLIN JA TORNABENE J LANNON MC DAVIES R FRIEDMAN J TARIOT PN HALL WJ HERNDON R PFEIFFER RF PLUMB S CASACELI C RANDOLPH H BEHMAN H CONNORTON J DAY D RUDOLPH A PELUSIO R GUTHRIE B CLAUDE K ORME C BAKER D NOBEL R IRVINE C WATTS A GORDIN A HEIKKINEN H RITA H
Citation: K. Kieburtz et al., ENTACAPONE IMPROVES MOTOR FLUCTUATIONS IN LEVODOPA-TREATED PARKINSONS-DISEASE PATIENTS, Annals of neurology, 42(5), 1997, pp. 747-755
NON-PHYSICIAN-BASED CONTINUOUS MEASURES OF MANUAL DEXTERITY AND AMBULATION CAN BE USED TO IMPROVE THE ABILITY OF THE EDSS TO DETECT CLINICAL WORSENING IN AN MS CLINICAL-TRIAL
Authors: GOODKIN DE PRIORE R WENDE K BOURDETTE D HERNDON R JACOBS L
Citation: De. Goodkin et al., NON-PHYSICIAN-BASED CONTINUOUS MEASURES OF MANUAL DEXTERITY AND AMBULATION CAN BE USED TO IMPROVE THE ABILITY OF THE EDSS TO DETECT CLINICAL WORSENING IN AN MS CLINICAL-TRIAL, Annals of neurology, 42(3), 1997, pp. 292-292
THE 5-YEAR RISK OF MS AFTER OPTIC NEURITIS - EXPERIENCE OF THE OPTIC NEURITIS TREATMENT TRIAL
Authors: BRODSKY M JAY W JOHNSON P LAMEY D CAIN S WHEELER B LAM B NAZARIAN S NICHOLS J BUCKHOLTS A FORD R ORENGONANIA S MCCRARY J ROLAK L SLIGHT B CHUNG S GROSS R HOWARD A LAI E FRADY P KATZ B FOLTOS C AMBROSIO T CRUZ T HAWKER N SWAHN T BARSNESS D CHRISTKUHN J GAFFNEY M LOEY N BUCKLEY E ANDERSON M VALENTINE G MASSEY E POLLOCK S RADTKE R DUNCAN L PATTERSON D GUY J ZAM S BURKE R FRANCIS A SHAMIS D CHROUSOS G BURT E KATTAH J GOODWIN J ASLAN R LINDEMAN M SULLIVAN L BOBAK P THOMPSON S CORBETT J MUSSER C DONAHUE S FARRELL T JOHNSTONMCNUSSEN P KARDON R MISHRA A NEAHRING R WALL M FOUNTAIN C SAVINO P WARD S DEVLIN N BOSLEY T CANTOR C MCCLOSKEY L SERGOTT R DAVIS A EDWARDS R MORTON D MILLER N MEDURA M PUTZULO C BUCHHOLZ D REICH S REPKA T WEST L TROBE J CASTILLO R CAUDILL C CORNBLATH W MICHAEL B KAUFMAN D HOLLIDAY S BICKERT S FROEHLICH J KOKINAKIS J EGGENBERGER E MYINT S BARRIS M ROSICK E KUPERSMITH M LANGER R ADDESSI A WEINMAN J FROMER E WAHBA S SHULTS W BOLY L BEARDSLEY C DREYER R HERNDON R WILSON R ARENDS J BEAUDRY T SMITH C KUDER D MACKINNON G SMITH S SPARENBURG J TRAN E BECK R MOKE P ZAJAC L BLAIR RC LESTER L GILLESPIE H MISKALA P JUREIDINI F KAHN D MHAMDI M KELTNER J JOHNSON C SPURR J SHAPIRO L HAKIM H CLAUNCH D BEAM D OWENSBY D ANDERSON MA CLEARY P PATY D MOWERY R EVERETT D
Citation: M. Brodsky et al., THE 5-YEAR RISK OF MS AFTER OPTIC NEURITIS - EXPERIENCE OF THE OPTIC NEURITIS TREATMENT TRIAL, Neurology, 49(5), 1997, pp. 1404-1413
FATIGUE SEVERITY IN LOW DISABILITY MS PATIENTS PARTICIPATING IN A PHASE-III TRIAL OF AVONEX(TM) (IFN-BETA-1A) FOR RELAPSING MULTIPLE-SCLEROSIS
Authors: COOKFAIR DL FISCHER J RUDICK R JACOBS L HERNDON R RICHERT J SALAZAR A GRANGER C SIMON J GOODKIN D
Citation: Dl. Cookfair et al., FATIGUE SEVERITY IN LOW DISABILITY MS PATIENTS PARTICIPATING IN A PHASE-III TRIAL OF AVONEX(TM) (IFN-BETA-1A) FOR RELAPSING MULTIPLE-SCLEROSIS, Neurology, 48(3), 1997, pp. 3066-3066
SIGNIFICANCE OF SERUM NEUTRALIZING ANTIBODIES TO AVONEX' (IFN-BETA-1A) IN MULTIPLE-SCLEROSIS
Authors: RUDICK RA JONES W ALAM J SIMONIAN N CAMPION M JACOBS L HERNDON R RICHERT J SALAZAR A COOKFAIR D SIMON J COATS M GOODKIN D MASS M
Citation: Ra. Rudick et al., SIGNIFICANCE OF SERUM NEUTRALIZING ANTIBODIES TO AVONEX' (IFN-BETA-1A) IN MULTIPLE-SCLEROSIS, Neurology, 48(3), 1997, pp. 5003-5003
CEREBROSPINAL-FLUID ABNORMALITIES IN A PHASE-III TRIAL INTERFERON BETA-1A (AVONEX) FOR RELAPSING MULTIPLE-SCLEROSIS
Authors: RUDICK RA COOKFAIR RD RANSOHOFF R JACOBS L HERNDON R RICHERT J SALAZAR A FISCHER J GRANGER C SIMON J GOODKIN D
Citation: Ra. Rudick et al., CEREBROSPINAL-FLUID ABNORMALITIES IN A PHASE-III TRIAL INTERFERON BETA-1A (AVONEX) FOR RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 40(3), 1996, pp. 104-104
QUALITY-OF-LIFE IN LOW-DISABILITY MULTIPLE-SCLEROSIS PATIENTS PARTICIPATING IN A PHASE-III TRIAL OF INTERFERON BETA-1A FOR RELAPSING MULTIPLE-SCLEROSIS
Authors: COOKFAIR DL FISCHER J RUDICK R BOURDETTE D OREILLY K JACOBS L HERNDON R RICHERT J SALAZAR A GRANGER C SIMON J GOODKIN D
Citation: Dl. Cookfair et al., QUALITY-OF-LIFE IN LOW-DISABILITY MULTIPLE-SCLEROSIS PATIENTS PARTICIPATING IN A PHASE-III TRIAL OF INTERFERON BETA-1A FOR RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 40(3), 1996, pp. 234-234
INTERFERON BETA-1A (AVONEX) INCREASES CEREBROSPINAL-FLUID INTERLEUKIN-10 IN PATIENTS WITH RELAPSING MULTIPLE-SCLEROSIS
Authors: RUDICK RA RANSOHOFF R MEDENDORP S BOYLE S PEPPLER R JACOBS L COCKFAIR D HERNDON R RICHERT J SALAZAR A FISCHER J GRANGER C SIMON J GOODKIN D WENDE K
Citation: Ra. Rudick et al., INTERFERON BETA-1A (AVONEX) INCREASES CEREBROSPINAL-FLUID INTERLEUKIN-10 IN PATIENTS WITH RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 40(3), 1996, pp. 244-244
EFFECT OF LAZABEMIDE ON THE PROGRESSION OF DISABILITY IN EARLY PARKINSONS-DISEASE
Authors: KIEBURTZ K MCDERMOTT M SHOULSON I FAHN S BRIN M GOETZ C LANG A OLANOW CW LEWITT P MISTURA K WATERS C WELSH M RODNITZKY R DOBSON J ARGATOFF P TANNER C LEWIS P WATTS R BRYAN B COMELLA C JAGLIN JA SHULTS C FONTAINE D BRESSMAN SB MOSKOWITZ C HURTIG HI SHALLOW K HUBBLE J BARTER R BENNETT JP ROSTRUFFNER E PERLMUTTER JS MCGEEMINNICH L HAUSER R GAUGER L RAJPUT AH SUTTON A TRINIDAD K GARDINER IF SINGER C SHELDON C FINK JS TENNIS M BAKER D BOURGEOIS K CASACELI C CLAUDE K HICKEY G NOBEL R OAKES D ORME C PELUSIO RM PLUMB S RUDOLPH A RANDOLPH P SOTACK J WATTS A TARIOT PN GOLBE LI MILLER P HALL WJ HERNDON R DORFLINGER E MYL D MODI M OARSLEY L YOO K ELIAHOU E SHIMOUN G COLLETTA S SIEGEL J PEDDER S DUPUIS D
Citation: K. Kieburtz et al., EFFECT OF LAZABEMIDE ON THE PROGRESSION OF DISABILITY IN EARLY PARKINSONS-DISEASE, Annals of neurology, 40(1), 1996, pp. 99-107
TOXICITY OF RECOMBINANT INTRAMUSCULAR RECOMBINANT INTERFERON-BETA-1A IN MULTIPLE-SCLEROSIS PATIENTS
Authors: RUDICK RA JACOBS L ALAM J COOKFAIR D HERNDON R RICHERT J SALAZAR A FISCHER J GOODKIN D GRANGER C SIMON J
Citation: Ra. Rudick et al., TOXICITY OF RECOMBINANT INTRAMUSCULAR RECOMBINANT INTERFERON-BETA-1A IN MULTIPLE-SCLEROSIS PATIENTS, Annals of neurology, 38(2), 1995, pp. 313-313
THE NATURAL-HISTORY OF MS BASED ON AN ANNUAL MR SNAPSHOT - RESULTS FROM THE MSCRG STUDY OF INTRAMUSCULAR RECOMBINANT INTERFERON-BETA-1A
Authors: SIMON JH JACOBS L COOKFAIR D RUDICK R HERNDON R SALAZAR A RICHERT J CHOI K FISCHER J GOODKIN D GRANGER C
Citation: Jh. Simon et al., THE NATURAL-HISTORY OF MS BASED ON AN ANNUAL MR SNAPSHOT - RESULTS FROM THE MSCRG STUDY OF INTRAMUSCULAR RECOMBINANT INTERFERON-BETA-1A, Neurology, 45(4), 1995, pp. 418-418
ADVANCES IN SPECIFIC THERAPY FOR MULTIPLE-SCLEROSIS
Authors: JACOBS L GOODKIN DE RUDICK RA HERNDON R
Citation: L. Jacobs et al., ADVANCES IN SPECIFIC THERAPY FOR MULTIPLE-SCLEROSIS, Current opinion in neurology, 7(3), 1994, pp. 250-254
RESULTS OF A PHASE-III TRIAL OF INTRAMUSCULAR RECOMBINANT BETA-INTERFERON AS TREATMENT FOR MULTIPLE-SCLEROSIS
Authors: JACOBS L COOKFAIR D RUDICK R HERNDON R RICHERT J SALAZAR A FISCHER J GRANGER C SIMON J GOODKIN D
Citation: L. Jacobs et al., RESULTS OF A PHASE-III TRIAL OF INTRAMUSCULAR RECOMBINANT BETA-INTERFERON AS TREATMENT FOR MULTIPLE-SCLEROSIS, Annals of neurology, 36(2), 1994, pp. 259-259
A CONTROLLED TRIAL OF LAZABEMIDE (RO-19-6327) IN LEVODOPA-TREATED PARKINSONS-DISEASE
Authors: KIEBURTZ K MCDERMOTT M SHOULSON I OAKES D FAHN S LANG A PENNEY JB RODNITZKY R SHULTS C TANNER C TETRUD J GORDON M LEWITT P BENNETT J KOLLER W FRIEDMAN JH KURLAN R OBRIEN C MARK MH WEINER WJ SANCHEZRAMOS J PAULSON G COMELLA C JANKOVIC J OLANOW W SHANNON K LEWIS P WINFIELD L CIECIERSKI K MISTURA K LANDOW E DIETRICH S GEBHARDT AM BARTER R KENNEDY D CULLEN KA GARDINER IF BERGEN M PATTERSON V FABRIELE M SHELDON C CORNELIUS L DUDTE K THELEN JA DUNNE C GAUGER L MALAPIRA T COURVILLE K TROTTER H PELUSIO RM RUDOLPH A CASACELI C MILLER C BOETTRICH C CONNORTON J BYRNE L ORME C BORDWELL K MCMANUS J SOTACK J RANDOLPH H KAVANAUGH B BAKER D RUMFOLA L NOBEL R EBERLY S PLUMB S WATTS A GERWITZ K DARCY S EVANS P FREDERICK D DELLAPENA L SINGLETARY V TARIOT P BELL E GRIGGS RC HALL WJ HERNDON R MARSDEN CD CHASE TN COHEN G FLEISS J JACOBS L MOSS AJ MELAMED E DORFLINGER E YOO K SHIMOUN G MORAWSKY L
Citation: K. Kieburtz et al., A CONTROLLED TRIAL OF LAZABEMIDE (RO-19-6327) IN LEVODOPA-TREATED PARKINSONS-DISEASE, Archives of neurology, 51(4), 1994, pp. 342-347
A PHASE-III TRIAL OF INTRAMUSCULAR RECOMBINANT INTERFERON-BETA AS TREATMENT FOR MULTIPLE-SCLEROSIS - CURRENT STATUS
Authors: JACOBS L COOKFAIR D RUDICK R HERNDON R SALAZAR A RICHERT J FISCHER J GOODKIN D GRANGER C SIMON J EMRICH L
Citation: L. Jacobs et al., A PHASE-III TRIAL OF INTRAMUSCULAR RECOMBINANT INTERFERON-BETA AS TREATMENT FOR MULTIPLE-SCLEROSIS - CURRENT STATUS, Annals of neurology, 34(2), 1993, pp. 310-310
INTERMITTENT CYCLOPHOSPHAMIDE PULSE THERAPY IN PROGRESSIVE MULTIPLE-SCLEROSIS - FINAL REPORT OF THE AST-COOPERATIVE-MULTIPLE-SCLEROSIS-TREATMENT-GROUP
Authors: WEINER HL MACKIN GA ORAV EJ HAFLER DA DAWSON DM LAPIERRE Y HERNDON R LEHRICH JR HAUSER SL TUREL A FISHER M BIRNBAUM G MCARTHUR J BUTLER R MOORE M SIGSBEE B SAFRAN A
Citation: Hl. Weiner et al., INTERMITTENT CYCLOPHOSPHAMIDE PULSE THERAPY IN PROGRESSIVE MULTIPLE-SCLEROSIS - FINAL REPORT OF THE AST-COOPERATIVE-MULTIPLE-SCLEROSIS-TREATMENT-GROUP, Neurology, 43(5), 1993, pp. 910-918
Risultati: 1-19 |